The FDA-approved drug sofosbuvir inhibits Zika virus infection

Antiviral Research

Volumn 137, Issue , 2017, Pages 134-140

  Bullard Feibelman, Kristen M ^a   Govero, Jennifer ^c   Zhu, Zhe ^d   Salazar, Vanessa ^c   Veselinovic, Milena ^a   Diamond, Michael S ^c   Geiss, Brian J ^a,b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b Engineering Research Center and Hydraulics Laboratory   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOFOSBUVIR; ANTIVIRUS AGENT;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG APPROVAL; EC50; EC90; FEMALE; FOOD AND DRUG ADMINISTRATION; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS STRAIN; ZIKA FEVER; ANIMAL; CELL LINE; DRUG EFFECTS; ORAL DRUG ADMINISTRATION; PRECLINICAL STUDY; UNITED STATES; VIROLOGY; ZIKA VIRUS;

ADMINISTRATION, ORAL; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DRUG APPROVAL; DRUG EVALUATION, PRECLINICAL; HUMANS; MICE; SOFOSBUVIR; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85000415085     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.11.023     Document Type: Article

References (58)

1. Aliota, M.T., Caine, E.A., Walker, E.C., Larkin, K.E., Camacho, E., Osorio, J.E., Characterization of lethal Zika virus infection in AG129 mice. PLoS Negl. Trop. Dis., 10, 2016, e0004682, 10.1371/journal.pntd.0004682.
2. Anderson, K.B., Thomas, S.J., Endy, T.P., The emergence of Zika virus: a narrative review. Ann. Intern. Med. 165 (2016), 175–183, 10.7326/M16-0617.
3. Araujo, L.M., Ferreira, M.L.B., Nascimento, O.J., Guillain-Barré syndrome associated with the Zika virus outbreak in Brazil. Arq. Neuropsiquiatr. 74 (2016), 253–255, 10.1590/0004-282X20160035.
4. Barzon, L., Pacenti, M., Franchin, E., Lavezzo, E., Trevisan, M., Sgarabotto, D., Palù, G., Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016. Euro Surveill., 21, 2016, 30316, 10.2807/1560-7917.ES.2016.21.32.30316.
5. Berden, F.A.C., Kievit, W., Baak, L.C., Bakker, C.M., Beuers, U., Boucher, C.A.B., Brouwer, J.T., Burger, D.M., van Erpecum, K.J.L., van Hoek, B., Hoepelman, A.I.M., Honkoop, P., Kerbert-Dreteler, M.J., de Knegt, R.J., Koek, G.H., van Nieuwkerk, C.M.J., van Soest, H., Tan, A.C.I.T.L., Vrolijk, J.M., Drenth, J.P.H., Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era. Neth J. Med. 72 (2014), 388–400.
6. Bollati, M., Milani, M., Mastrangelo, E., Ricagno, S., Tedeschi, G., Nonnis, S., Decroly, E., Selisko, B., de Lamballerie, X., Coutard, B., Canard, B., Bolognesi, M., Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus. J. Mol. Biol. 385 (2009), 140–152, 10.1016/j.jmb.2008.10.028.
7. Brasil, P., Pereira, J.P., Raja Gabaglia, C., Damasceno, L., Wakimoto, M., Ribeiro Nogueira, R.M., Carvalho de Sequeira, P., Machado Siqueira, A., Abreu de Carvalho, L.M., Cotrim da Cunha, D., Calvet, G.A., Neves, E.S., Moreira, M.E., Rodrigues Baião, A.E., Nassar de Carvalho, P.R., Janzen, C., Valderramos, S.G., Cherry, J.D., Bispo de Filippis, A.M., Nielsen-Saines, K., Zika virus infection in pregnant women in Rio de Janeiro - preliminary report. N. Engl. J. Med., 2016, 10.1056/NEJMoa1602412 NEJMoa1602412.
8. Brasil, P., Sequeira, P.C., Freitas, A.D., Zogbi, H.E., Calvet, G.A., de Souza, R.V., Siqueira, A.M., de Mendonca, M.C.L., Nogueira, R.M.R., de Filippis, A.M.B., Solomon, T., Guillain-Barré syndrome associated with Zika virus infection. Lancet, 387, 2016, 1482, 10.1016/S0140-6736(16)30058-7.
9. Cada, D.J., Cong, J., Baker, D.E., Sofosbuvir. Hosp. Pharm. 49 (2014), 466–478, 10.1310/hpj4905-466.
10. Cao-Lormeau, V.-M., Blake, A., Mons, S., Lastère, S., Roche, C., Vanhomwegen, J., Dub, T., Baudouin, L., Teissier, A., Larre, P., Vial, A.-L., Decam, C., Choumet, V., Halstead, S.K., Willison, H.J., Musset, L., Manuguerra, J.-C., Desprès, P., Fournier, E., Mallet, H.-P., Musso, D., Fontanet, A., Neil, J., Ghawché, F., Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387 (2016), 1531–1539, 10.1016/S0140-6736(16)00562-6.
11. Carteaux, G., Maquart, M., Bedet, A., Contou, D., Brugières, P., Fourati, S., Cleret de Langavant, L., de Broucker, T., Brun-Buisson, C., Leparc-Goffart, I., Mekontso Dessap, A., Zika virus associated with meningoencephalitis. N. Engl. J. Med. 374 (2016), 1595–1596, 10.1056/NEJMc1602964.
12. Choi, K.H., Groarke, J.M., Young, D.C., Kuhn, R.J., Smith, J.L., Pevear, D.C., Rossmann, M.G., The structure of the RNA-dependent RNA polymerase from bovine viral diarrhea virus establishes the role of GTP in de novo initiation. PNAS 101 (2004), 4425–4430, 10.1073/pnas.0400660101.
13. Cholongitas, E., Papatheodoridis, G.V., Sofosbuvir: a novel oral agent for chronic hepatitis C. Ann. Gastroenterol. 27 (2014), 331–337.
14. Deng, Y.-Q., Zhang, N.-N., Li, C.-F., Tian, M., Hao, J.-N., Xie, X.-P., Shi, P.-Y., Qin, C.-F., Adenosine analog NITD008 is a potent inhibitor of Zika virus. Open Forum Infect. Dis., 3, 2016, ofw175, 10.1093/ofid/ofw175.
15. Dick, G.W.A., Zika virus. II. Pathogenicity and physical properties. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 521–534.
16. Dick, G.W.A., Kitchen, S.F., Haddow, A.J., Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 509–520.
17. Dutartre, H., Bussetta, C., Boretto, J., Canard, B., General catalytic deficiency of hepatitis C virus RNA polymerase with an S282T mutation and mutually exclusive resistance towards 2'-modified nucleotide analogues. Antimicrob. Agents Chemother. 50 (2006), 4161–4169, 10.1128/AAC.00433-06.
18. Egloff, M.-P., Decroly, E., Malet, H., Selisko, B., Benarroch, D., Ferron, F., Canard, B., Structural and functional analysis of methylation and 5'-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5. J. Mol. Biol. 372 (2007), 723–736, 10.1016/j.jmb.2007.07.005.
19. Geiss, B.J., Thompson, A.A., Andrews, A.J., Sons, R.L., Gari, H.H., Keenan, S.M., Peersen, O.B., Analysis of flavivirus NS5 methyltransferase cap binding. J. Mol. Biol. 385 (2009), 1643–1654, 10.1016/j.jmb.2008.11.058.
20. Govero, J., Esakky, P., Scheaffer, S.M., Fernandez, E., Drury, A., Platt, D.J., Gorman, M.J., Richner, J.M., Caine, E.A., Salazar, V., Moley, K.H., Diamond, M.S., Zika virus infection damages the testes in mice. Nature, 2016, 10.1038/nature20556.
21. Grun, J.B., Brinton, M.A., Characterization of West Nile virus RNA-dependent RNA polymerase and cellular terminal adenylyl and uridylyl transferases in cell-free extracts. J. Virol. 60 (1986), 1113–1124.
22. Issur, M., Geiss, B.J., Bougie, I., Picard-Jean, F., Despins, S., Mayette, J., Hobdey, S.E., Bisaillon, M., The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure. RNA 15 (2009), 2340–2350, 10.1261/rna.1609709.
23. Keating, G.M., Vaidya, A., Sofosbuvir: first global approval. Drugs 74 (2014), 273–282, 10.1007/s40265-014-0179-7.
24. Koonin, E.V., Dolja, V.V., Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences. Crit. Rev. Biochem. Mol. Biol. 28 (1993), 375–430, 10.3109/10409239309078440.
25. Lam, A.M., Espiritu, C., Bansal, S., Micolochick Steuer, H.M., Niu, C., Zennou, V., Keilman, M., Zhu, Y., Lan, S., Otto, M.J., Furman, P.A., Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus. Antimicrob. Agents Chemother. 56 (2012), 3359–3368, 10.1128/AAC.00054-12.
26. Lazear, H.M., Diamond, M.S., Zika virus: new clinical syndromes and its emergence in the western hemisphere. J. Virol. 90 (2016), 4864–4875, 10.1128/JVI.00252-16.
27. Lazear, H.M., Govero, J., Smith, A.M., Platt, D.J., Fernandez, E., Miner, J.J., Diamond, M.S., A mouse model of Zika virus pathogenesis. Cell Host Microbe 19 (2016), 720–730, 10.1016/j.chom.2016.03.010.
28. Lessler, J., Chaisson, L.H., Kucirka, L.M., Bi, Q., Grantz, K., Salje, H., Carcelen, A.C., Ott, C.T., Sheffield, J.S., Ferguson, N.M., Cummings, D.A.T., Metcalf, C.J.E., Rodriguez-Barraquer, I., Assessing the global threat from Zika virus. Science, 353, 2016, 10.1126/science.aaf8160 aaf8160-aaf8160.
29. Lim, S.P., Noble, C.G., Shi, P.-Y., The dengue virus NS5 protein as a target for drug discovery. Antivir. Res. 119 (2015), 57–67, 10.1016/j.antiviral.2015.04.010.
30. Mansuy, J.M., Dutertre, M., Mengelle, C., Fourcade, C., Marchou, B., Delobel, P., Izopet, J., Martin-Blondel, G., Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen?. Lancet Infect. Dis., 16, 2016, 405, 10.1016/S1473-3099(16)00138-9.
31. Migliaccio, G., Tomassini, J.E., Carroll, S.S., Tomei, L., Altamura, S., Bhat, B., Bartholomew, L., Bosserman, M.R., Ceccacci, A., Colwell, L.F., Cortese, R., De Francesco, R., Eldrup, A.B., Getty, K.L., Hou, X.S., LaFemina, R.L., Ludmerer, S.W., MacCoss, M., McMasters, D.R., Stahlhut, M.W., Olsen, D.B., Hazuda, D.J., Flores, O.A., Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J. Biol. Chem. 278 (2003), 49164–49170, 10.1074/jbc.M305041200.
32. Miner, J.J., Cao, Bin, Govero, J., Smith, A.M., Fernandez, E., Cabrera, O.H., Garber, C., Noll, M., Klein, R.S., Noguchi, K.K., Mysorekar, I.U., Diamond, M.S., Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165 (2016), 1081–1091, 10.1016/j.cell.2016.05.008.
33. Miner, J.J., Sene, A., Richner, J.M., Smith, A.M., Santeford, A., Ban, N., Weger-Lucarelli, J., Manzella, F., Rückert, C., Govero, J., Noguchi, K.K., Ebel, G.D., Diamond, M.S., Apte, R.S., Zika virus infection in mice causes panuveitis with shedding of virus in tears. Cell Rep. 16 (2016), 3208–3218, 10.1016/j.celrep.2016.08.079.
34. Murakami, E., Tolstykh, T., Bao, H., Niu, C., Steuer, H.M.M., Bao, D., Chang, W., Espiritu, C., Bansal, S., Lam, A.M., Otto, M.J., Sofia, M.J., Furman, P.A., Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977. J. Biol. Chem. 285 (2010), 34337–34347, 10.1074/jbc.M110.161802.
35. Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastere, S., Valour, F., Baudouin, L., Mallet, H., Musso, D., Ghawche, F., Zika Virus Infection Complicated by Guillain-Barre Syndrome–case Report. French Polynesia, December 2013. Euro Surveill. 19, 2014.
36. Onorati, M., Li, Z., Liu, F., Sousa, A.M.M., Nakagawa, N., Li, M., Dell'Anno, M.T., Gulden, F.O., Pochareddy, S., Tebbenkamp, A.T.N., Han, W., Pletikos, M., Gao, T., Zhu, Y., Bichsel, C., Varela, L., Szigeti-Buck, K., Lisgo, S., Zhang, Y., Testen, A., Gao, X.-B., Mlakar, J., Popovic, M., Flamand, M., Strittmatter, S.M., Kaczmarek, L.K., Anton, E.S., Horvath, T.L., Lindenbach, B.D., Sestan, N., Zika virus disrupts phospho-TBK1 localization and mitosis in human neuroepithelial stem cells and radial glia. Cell Rep. 16 (2016), 2576–2592, 10.1016/j.celrep.2016.08.038.
37. Osinusi, A., Meissner, E.G., Lee, Y.-J., Bon, D., Heytens, L., Nelson, A., Sneller, M., Kohli, A., Barrett, L., Proschan, M., Herrmann, E., Shivakumar, B., Gu, W., Kwan, R., Teferi, G., Talwani, R., Silk, R., Kotb, C., Wroblewski, S., Fishbein, D., Dewar, R., Highbarger, H., Zhang, X., Kleiner, D., Wood, B.J., Chavez, J., Symonds, W.T., Subramanian, M., McHutchison, J., Polis, M.A., Fauci, A.S., Masur, H., Kottilil, S., Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. JAMA 310 (2013), 804–811, 10.1001/jama.2013.109309.
38. Paploski, I.A.D., Prates, A.P.P.B., Cardoso, C.W., Kikuti, M., Silva, M.M.O., Waller, L.A., Reis, M.G., Kitron, U., Ribeiro, G.S., Time lags between exanthematous illness attributed to Zika virus, Guillain-Barré syndrome, and microcephaly, Salvador, Brazil. Emerg. Infect. Dis. 22 (2016), 1438–1444, 10.3201/eid2208.160496.
39. Petersen, E.E., Staples, J.E., Meaney-Delman, D., Fischer, M., Ellington, S.R., Callaghan, W.M., Jamieson, D.J., Interim guidelines for pregnant women during a Zika Virus outbreak–United States, 2016. MMWR Morb. Mortal. Wkly. Rep. 65 (2016), 30–33, 10.15585/mmwr.mm6502e1.
40. Petersen, L.R., Jamieson, D.J., Powers, A.M., Honein, M.A., Zika virus. N. Engl. J. Med. 374 (2016), 1552–1563, 10.1056/NEJMra1602113.
41. Ramirez, S., Li, Y.-P., Jensen, S.B., Pedersen, J., Gottwein, J.M., Bukh, J., Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors. Hepatology 59 (2014), 395–407, 10.1002/hep.26660.
42. Ramirez, S., Mikkelsen, L.S., Gottwein, J.M., Bukh, J., Robust HCV genotype 3a infectious cell culture system permits identification of escape variants with resistance to sofosbuvir. Gastroenterology, 2016, 10.1053/j.gastro.2016.07.013.
43. Rasmussen, S.A., Jamieson, D.J., Honein, M.A., Petersen, L.R., Zika virus and birth defects–reviewing the evidence for causality. N. Engl. J. Med. 374 (2016), 1981–1987, 10.1056/NEJMsr1604338.
44. Regan, C.P., Morissette, P., Regan, H.K., Travis, J.J., Gerenser, P., Wen, J., Fitzgerald, K., Gruver, S., DeGeorge, J.J., Sannajust, F.J., Assessment of the clinical cardiac drug-drug interaction associated with the combination of hepatitis C virus nucleotide inhibitors and amiodarone in Guinea pigs and rhesus monkeys. Hepatology, 2016, 10.1002/hep.28752.
45. Rodriguez-Torres, M., Lawitz, E., Kowdley, K.V., Nelson, D.R., Dejesus, E., McHutchison, J.G., Cornpropst, M.T., Mader, M., Albanis, E., Jiang, D., Hebner, C.M., Symonds, W.T., Berrey, M.M., Lalezari, J., Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial. J. Hepatol. 58 (2013), 663–668, 10.1016/j.jhep.2012.11.018.
46. Rong, L., Dahari, H., Ribeiro, R.M., Perelson, A.S., Rapid emergence of protease inhibitor resistance in hepatitis C virus. Sci. Transl. Med., 2, 2010, 10.1126/scitranslmed.3000544 30ra32-30ra32.
47. Sarrazin, C., Zeuzem, S., Resistance to direct antiviral agents in patients with hepatitis C virus infection. Gastroenterology 138 (2010), 447–462, 10.1053/j.gastro.2009.11.055.
48. Sofia, M.J., Bao, D., Chang, W., Du, J., Nagarathnam, D., Rachakonda, S., Reddy, P.G., Ross, B.S., Wang, P., Zhang, H.-R., Bansal, S., Espiritu, C., Keilman, M., Lam, A.M., Steuer, H.M.M., Niu, C., Otto, M.J., Furman, P.A., Discovery of a β- d-2′-Deoxy-2′-α-fluoro-2′-β- C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. J. Med. Chem. 53 (2010), 7202–7218, 10.1021/jm100863x.
49. Stahla-Beek, H.J., April, D.G., Saeedi, B.J., Hannah, A.M., Keenan, S.M., Geiss, B.J., Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme. J. Virol. 86 (2012), 8730–8739, 10.1128/JVI.00384-12.
50. Swaminathan, S., Schlaberg, R., Lewis, J., Hanson, K.E., Couturier, M.R., N. Engl. J. Med. 375 (2016), 1907–1909, 10.1056/NEJMc1610613.
51. Tan, B.H., Fu, J., Sugrue, R.J., Yap, E.H., Chan, Y.C., Tan, Y.H., Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology 216 (1996), 317–325, 10.1006/viro.1996.0067.
52. Turmel, J.M., Abgueguen, P., Hubert, B., Vandamme, Y.M., Maquart, M., Le Guillou-Guillemette, H., Leparc-Goffart, I., Late sexual transmission of Zika virus related to persistence in the semen. Lancet, 387, 2016, 2501, 10.1016/S0140-6736(16)30775-9.
53. Xu, M., Lee, E.M., Wen, Z., Cheng, Y., Huang, W.-K., Qian, X., Tcw, J., Kouznetsova, J., Ogden, S.C., Hammack, C., Jacob, F., Nguyen, H.N., Itkin, M., Hanna, C., Shinn, P., Allen, C., Michael, S.G., Simeonov, A., Huang, W., Christian, K.M., Goate, A., Brennand, K.J., Huang, R., Xia, M., Ming, G.-L., Zheng, W., Song, H., Tang, H., Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat. Med., 2016, 10.1038/nm.4184.
54. Ye, Q., Liu, Z.-Y., Han, J.-F., Jiang, T., Li, X.-F., Qin, C.-F., Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas. Infect. Genet. Evol. 43 (2016), 43–49, 10.1016/j.meegid.2016.05.004.
55. Zhao, H., Fernandez, E., Dowd, K.A., Speer, S.D., Platt, D.J., Gorman, M.J., Govero, J., Nelson, C.A., Pierson, T.C., Diamond, M.S., Fremont, D.H., Structural basis of Zika virus-specific antibody protection. Cell, 2016, 1–26, 10.1016/j.cell.2016.07.020.
56. Zmurko, J., Marques, R.E., Schols, D., Verbeken, E., Kaptein, S.J.F., Neyts, J., The viral polymerase inhibitor 7-deaza-2'-C-methyladenosine is a potent inhibitor of in vitro Zika virus replication and delays disease progression in a robust mouse infection model. PLoS Negl. Trop. Dis., 10, 2016, e0004695, 10.1371/journal.pntd.0004695.
57. Zonneveld, R., Roosblad, J., Staveren, J.W.V., Wilschut, J.C., Vreden, S.G.S., Codrington, J., Three atypical lethal cases associated with acute Zika virus infection in Suriname. IDCases 5 (2016), 49–53, 10.1016/j.idcr.2016.07.009.
58. Zou, G., Chen, Y.-L., Dong, H., Lim, C.C., Yap, L.J., Yau, Y.H., Shochat, S.G., Lescar, J., Shi, P.-Y., Functional analysis of two cavities in flavivirus NS5 polymerase. J. Biol. Chem. 286 (2011), 14362–14372, 10.1074/jbc.M110.214189.